5-Hydroxy-1,2-naphthalenedicarboxylic anhydride is identified as the first molecule derived from a carcinogen that inhibits oxidative phosphorylation similarly to rutamycin.
Answers are grounded in this paper and cite their sources.
First carcinogen-derived oxidative phosphorylation inhibitor identified; hypothesis-generating for mitochondrial mechanisms in cancer.
5-Hydroxy-1,2-naphthalenedicarboxylic anhydride is closely related to its precursor dibasic acid which is a metabolite of the carcinogenic polynuclear hydrocarbon dibenz[a,h]anthracene. The anhydride inhibited respiration of coupled mitochondria. This inhibition was relieved by 2,4-dinitrophenol. Several mitochondrial volume change processes energized by ATP were also inhibited by the anhydride. Both the mitochondrial ATPase activity induced by 2,4-dinitrophenol and the ATPase activity of submitochondrial particles induced by magnesium ion were inhibited by the anhydride. The spectrum of inhibitory activity was not associated with acetic anhydride, succinic anhydride, or phthalic anhydride. The data indicate that 5-hydroxy-1,2-naphthalenedicarboxylic anhydride inhibits the machinery of oxidative phosphorylation in a manner similar to rutamycin. 5-Hydroxy-1,2-naphthalenedicarboxylic anhydride is the first molecule derived from a carcinogen with such inhibitory properties.
No takes yet. Share an insight, caveat, or question.
Hadler et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: